Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus.

J Virol

Department of Cell Biology and Center for Integrative Molecular Biosciences, The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037, USA.

Published: February 2007

Cowpea mosaic virus (CPMV), a plant virus that is a member of the picornavirus superfamily, is increasingly being used for nanotechnology applications, including material science, vascular imaging, vaccine development, and targeted drug delivery. For these applications, it is critical to understand the in vivo interactions of CPMV within the mammalian system. Although the bioavailability of CPMV in the mouse has been demonstrated, the specific interactions between CPMV and mammalian cells need to be characterized further. Here we demonstrate that although the host range for replication of CPMV is confined to plants, mammalian cells nevertheless bind and internalize CPMV in significant amounts. This binding is mediated by a conserved 54-kDa protein found on the plasma membranes of both human and murine cell lines. Studies using a deficient cell line, deglycosidases, and glycosylation inhibitors showed that the CPMV binding protein (CPMV-BP) is not glycosylated. A possible 47-kDa isoform of the CPMV-BP was also detected in the organelle and nuclear subcellular fraction prepared from murine fibroblasts. Further characterization of CPMV-BP is important to understand how CPMV is trafficked through the mammalian system and may shed light on how picornaviruses may have evolved between plant and animal hosts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797570PMC
http://dx.doi.org/10.1128/JVI.00960-06DOI Listing

Publication Analysis

Top Keywords

cowpea mosaic
8
mosaic virus
8
cpmv
8
interactions cpmv
8
cpmv mammalian
8
mammalian system
8
mammalian cells
8
mammalian
5
interaction 54-kilodalton
4
54-kilodalton mammalian
4

Similar Publications

This study aims to enhance sustainable disease management in black gram by identifying varieties resistant to Mungbean Yellow Mosaic India Virus (MYMIV). We screened sixteen black gram genotypes, assessing physiological, biochemical and enzymatic basis. Results revealed a range of resistance levels, with PANT URD-19 showing the highest resistance (PDI 0.

View Article and Find Full Text PDF

Blackgram is an important short-duration grain legume, but its yield is highly affected by various stresses. Among biotic stresses, yellow mosaic disease (YMD) is known as a devastating disease that leads to 100% yield loss under severe conditions. The cultivated lines possess resistance, but exploring more diverse sources of resistance may be useful for pyramiding to improve the durability of said resistance.

View Article and Find Full Text PDF

The mungbean yellow mosaic India virus (MYMIV, Begomovirus vignaradiataindiaense) causes Yellow Mosaic Disease (YMD) in mungbean (Vigna radiata L.). The biochemical assays including total phenol content (TPC), total flavonoid content (TFC), ascorbic acid (AA), DPPH (2,2-diphenyl-1-picrylhydrazyl), and FRAP (Ferric Reducing Antioxidant Power) were used to study the mungbean plants defense response to MYMIV infection.

View Article and Find Full Text PDF

Unlabelled: Seed transmission (ST) plays an important role in virus dispersion and disease epidemiology. Many viruses infecting cowpea are known to be seed-transmitted. This study evaluated the rate of virus ST in cowpea varieties inoculated under screenhouse conditions (SC) with bean common mosaic virus-blackeye cowpea mosaic strain (BCMV-BlCM), Southern bean mosaic virus (SBMV) and cucumber mosaic virus (CMV) under single and multiple-infections.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers are exploring the TLR3 agonist poly(I:C) encapsulated in cowpea chlorotic mottle virus (CCMV) nanoparticles, which showed effectiveness in stimulating immune cells and reducing tumor growth in mouse models of colon cancer and melanoma.
  • * The combination of CCMV-poly(I:C) with the chemotherapy drug oxaliplatin demonstrated enhanced anti-tumor effects, promoting immune cell activity and leading to increased tumor cell death, suggesting a promising approach in cancer treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!